ULTRAVIOLET LIGHT INDUCED PHENOMENA IN BIOMEMBRANES

生物膜中的紫外线诱导现象

基本信息

  • 批准号:
    2175899
  • 负责人:
  • 金额:
    $ 25.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1981
  • 资助国家:
    美国
  • 起止时间:
    1981-09-01 至 1996-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the applicant's abstract): The long-range goal of this application is to understand basic photochemical and photobiological processes needed to minimize drug phototoxicity responses and to design new drugs and approaches for rational application of membrane photosensitization in medicine and biology. This application has two specific aims: (1) To relate reactive species in membrane photosensitization and their site of formation to biochemical changes produced in the cell plasma membrane and to cell functional changes. This fundamental information can be used to design dyes for photochemically initiated treatments and for explaining the effects of phototoxic drugs. Membrane photosensitization involving singlet oxygen or aryl/halide radicals produced from phototoxic drugs will be compared by measuring changes in plasma membrane potential, active transport, and membrane permeability in keratinocyte and myelomonocytic cell lines. The influence of photosensitizer location will be determined by creating the same reactive species within and outside of the membrane and by creating different reactive species at the same locations within membranes. The relationship between mechanism for membrane damage and alteration of membrane-mediated cell functions will be assessed for photosensitized inhibition of mast cell degranulation, release of arachidonic acid by keratinocytes, and inhibition of antigen presentation. (2) Determine the mechanisms by which high intensity laser radiation can influence the efficiency of membrane photosensitization. Use of high intensity radiation can alter photosensitization efficiency and introduce nonoxygen-dependent mechanisms. These effects may be useful in photodynamic therapy of hypoxic regions of tumors and other photosensitization treatments. The relationship will be established between radiation intensity and the yield of photosensitizer excited states, the subsequent absorption of a photon by the excited states, and the yields of reactive species. Photophysical studies will employ Rose Bengal and merocyanine 540 in liposomes and RBC membranes. The ability to predict the efficiency of intensity-dependent photosensitization from photophysical measurements will be tested. Photobiological studies will measure photosensitized inhibition of RBC membrane enzyme activities and cytotoxicity to a leukemia cell line using high laser radiation intensities.
描述(改编自申请人摘要):长期目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IRENE KOCHEVAR其他文献

IRENE KOCHEVAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IRENE KOCHEVAR', 18)}}的其他基金

MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    2800596
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    2442850
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    6632628
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    2732880
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    6511871
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    2083651
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    6045349
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR-INDUCED DAMAGE TO SKIN
紫外线引起的皮肤慢性损伤的机制
  • 批准号:
    6375020
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
MECHANISMS FOR CHRONIC UVR INDUCED DAMAGE TO SKIN
慢性紫外线对皮肤造成损害的机制
  • 批准号:
    2807300
  • 财政年份:
    1996
  • 资助金额:
    $ 25.39万
  • 项目类别:
ULTRAVIOLET LIGHT INDUCED PHENOMENA IN BIOMEMBRANES
生物膜中的紫外线诱导现象
  • 批准号:
    3278615
  • 财政年份:
    1981
  • 资助金额:
    $ 25.39万
  • 项目类别:

相似海外基金

Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
  • 批准号:
    10836880
  • 财政年份:
    2023
  • 资助金额:
    $ 25.39万
  • 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
  • 批准号:
    10734324
  • 财政年份:
    2023
  • 资助金额:
    $ 25.39万
  • 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
  • 批准号:
    10740465
  • 财政年份:
    2023
  • 资助金额:
    $ 25.39万
  • 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
  • 批准号:
    23K04971
  • 财政年份:
    2023
  • 资助金额:
    $ 25.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
  • 批准号:
    2885451
  • 财政年份:
    2023
  • 资助金额:
    $ 25.39万
  • 项目类别:
    Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
  • 批准号:
    10385926
  • 财政年份:
    2022
  • 资助金额:
    $ 25.39万
  • 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
  • 批准号:
    10509043
  • 财政年份:
    2022
  • 资助金额:
    $ 25.39万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10704008
  • 财政年份:
    2022
  • 资助金额:
    $ 25.39万
  • 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
  • 批准号:
    10818273
  • 财政年份:
    2022
  • 资助金额:
    $ 25.39万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10349397
  • 财政年份:
    2022
  • 资助金额:
    $ 25.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了